Live Markets, Charts & Financial News

Immutep stock slips after share offering (NASDAQ:IMMP)

0 10

Daniel Grzelj

ADRs of Immutep Limited (Nasdaq: IMP) fell on Wednesday after the Australian biotechnology company announced the conclusion of a share offering targeting institutional investors.

The Sydney-based cancer drug developer said the offer, which includes an institutional placement component (Placement) and an institutional accrual component (Institutional).

Leave A Reply

Your email address will not be published.